期刊文献+

恶性嗜铬细胞瘤的非手术治疗进展

Non-operative treatment for malignant pheochromocytoma
原文传递
导出
摘要 恶性嗜铬细胞瘤的治疗包括外科手术、^131l-间碘苄胍(MIBG)放射治疗、化学治疗和动脉栓塞治疗等。从疗效看,^131l-MIBG放射治疗和环磷酰胺、长春新碱以及氮烯咪胺联合化学治疗是比较有效的治疗方法,且不良反应相对较小。热休克蛋门(HSP)90抑制剂是一具有诱人前景的新型抗肿瘤药。本文对恶性嗜铬细胞瘤的非手术治疗方法进行简要综述。 Treatments for malignant pheochromocytoma include surgical debulking, ^131l-MIBG radiotherapy, chemotherapy and transcatheter arterial embolization. MIBG radiotherapy and combined chemothera- py of cyclophusphamide,vincristine, dacarbazine are comparable with respect to response rate and toxicity. Inhibition of HSP90 is an important element of multi-modal concepts for therapy of malignant pheochromocytoma. This review focuses on the recent advances in the non-operative treatment for malignant pheochromocytoma.
出处 《国际内分泌代谢杂志》 2008年第4期270-272,共3页 International Journal of Endocrinology and Metabolism
基金 国家科技攻关计划(2004BA720A29)
关键词 恶性嗜铬细胞瘤 ^131I-MIBG 放射治疗 化学治疗 Malignant pheoehromoeytoma ^131l-MIBG Radiotherapy Chemotherapy
  • 相关文献

参考文献17

  • 1Fitzgerald PA, Goldsby RE, Huberty JP, et al. Malignant pheochromocytomas and paragangliomas: a phase Ⅱ study of therapy with high-dose ^131I-metaiodobenzylguanidine ( ^131I-MIBG), Ann N Y Acad Sci ,2006,1073:465-490.
  • 2Rose B, Matthay KK, Price D, et al. High-dose ^131I-MIBG therapy for 12 patients with malignant pheochromoeytoma. Cancer,2003,98:239-248.
  • 3Gedik GK, Hoefnagel CA, Bais E, et al. ( 131 )I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol hnaging,2008 ,35 :725-733.
  • 4Lain MG, Lips CJ, Jager PL, et al. Repeated [ ^131I ] metaiodo- benzylguanidine therapy in two patients with malignant pheochromocytoma. J Clin Endocrinol Metab,2005,90:5888-5895.
  • 5Basu S, Nair N. Stable disease and improved health-related quality of life (HRQoL) following fraetionated low dose ^131I-metaiodobenzylguanidine (MIBG) therapy in metastatic paediatric paraganglioma: observation on false " reverse" discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy. Br J Radiol,2006,79 :e53-e58.
  • 6Kantor L, Zhang M, Guptaroy B, et al. Repeated amphetamine couples norepinephrine transporter and calcium channel activities in PC12 cells. J Pharmacol Exp Ther,2004,311 : 1044-1051.
  • 7Edstrom Elder E, l-Ijehn Skog AL, Hoog A, et al. The management of benign and malignant pheoehromoeytoma and abdominal paraganglioma. Eur J Surg Oncol,2003 ,29 :278-283.
  • 8Uemura M, Nakagawa M, Mukai M,et al. A case of extra-adrenal pheoehromoeytoma presenting with lung metastasis. Hinyokika Kiyo, 2004,50 : 29-32.
  • 9Kulke MH,Stuart K, Enzinger PC, et al. Phase Ⅱ study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol,2006 ,20 :401-406.
  • 10Forssell-Aronsson E, Bernhardt P, Wangberg B, et al, Aspects on radionuclide therapy in malignant pheochromocytomas. Ann N Y Acad Sci ,2006,1073:498-504.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部